Publication | Closed Access

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy

Bone DiseaseBone HealthOpen TherapyOsteopathyBlinded TherapyOrthopaedicsFour-year StudyOsteoporosisMedicineOrthopaedic Surgery